ENTITY

NuvOx Therapeutics (NUOX US)

2
Analysis
Health Care • United States
NuvOx Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative oxygen therapeutic solutions for diseases where hypoxia plays a critical role. Its product candidate, NanO2, is administered intravenously to deliver oxygen to tissues, with clinical research focused on acute ischemic stroke, glioblastoma multiforme (GBM), and acute respiratory distress syndrome (ARDS).
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x